DE69232547T2 - Keramische Partikel und Verfahren zur ihren Herstellung - Google Patents

Keramische Partikel und Verfahren zur ihren Herstellung

Info

Publication number
DE69232547T2
DE69232547T2 DE69232547T DE69232547T DE69232547T2 DE 69232547 T2 DE69232547 T2 DE 69232547T2 DE 69232547 T DE69232547 T DE 69232547T DE 69232547 T DE69232547 T DE 69232547T DE 69232547 T2 DE69232547 T2 DE 69232547T2
Authority
DE
Germany
Prior art keywords
manufacture
ceramic particles
ceramic
particles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69232547T
Other languages
English (en)
Other versions
DE69232547D1 (de
Inventor
Aaron Gershon Filler
Andrew Michael Lindsay Lever
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syngenix Ltd
Original Assignee
Syngenix Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syngenix Ltd filed Critical Syngenix Ltd
Publication of DE69232547D1 publication Critical patent/DE69232547D1/de
Application granted granted Critical
Publication of DE69232547T2 publication Critical patent/DE69232547T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
    • A61K47/6923—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being an inorganic particle, e.g. ceramic particles, silica particles, ferrite or synsorb
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
    • A61K47/6925—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a microcapsule, nanocapsule, microbubble or nanobubble
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Ceramic Engineering (AREA)
  • Inorganic Chemistry (AREA)
  • Nanotechnology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69232547T 1991-09-16 1992-09-16 Keramische Partikel und Verfahren zur ihren Herstellung Expired - Fee Related DE69232547T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919119762A GB9119762D0 (en) 1991-09-16 1991-09-16 Particulate agents for nmt

Publications (2)

Publication Number Publication Date
DE69232547D1 DE69232547D1 (de) 2002-05-16
DE69232547T2 true DE69232547T2 (de) 2002-11-28

Family

ID=10701480

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69232547T Expired - Fee Related DE69232547T2 (de) 1991-09-16 1992-09-16 Keramische Partikel und Verfahren zur ihren Herstellung

Country Status (10)

Country Link
US (2) US6153598A (de)
EP (2) EP0610232A1 (de)
JP (1) JP3560969B2 (de)
AU (1) AU669128B2 (de)
CA (1) CA2119145C (de)
DE (1) DE69232547T2 (de)
DK (1) DK0640350T3 (de)
ES (1) ES2176216T3 (de)
GB (1) GB9119762D0 (de)
WO (1) WO1993005815A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6919067B2 (en) 1991-09-13 2005-07-19 Syngenix Limited Compositions comprising a tissue glue and therapeutic agents
GB9119762D0 (en) * 1991-09-16 1991-10-30 Filler Aaron G Particulate agents for nmt
GB2282139A (en) * 1993-09-24 1995-03-29 Univ Reading Introducing DNA into the germ line of birds
US5534423A (en) * 1993-10-08 1996-07-09 Regents Of The University Of Michigan Methods of increasing rates of infection by directing motion of vectors
US5811274A (en) * 1994-12-09 1998-09-22 The Regents Of The University Of Michigan Methods, compositions and apparatus for cell transfection
WO1996040273A2 (en) * 1995-06-07 1996-12-19 Schering Aktiengesellschaft Conjugates of ferrites and oligonucleotides, which bond specifically to certain target structures
AU1194697A (en) * 1995-12-21 1997-07-17 Quest International B.V. Particle compositions
FR2762615B1 (fr) * 1997-04-28 1999-07-16 Inst Nat Sante Rech Med Nouveau site interne d'entree des ribosomes et vecteur le contenant
US6372722B1 (en) 2000-01-19 2002-04-16 Genteric, Inc. Method for nucleic acid transfection of cells
WO2002000870A2 (en) * 2000-06-26 2002-01-03 Christian Plank Method for transfecting cells using a magnetic field
WO2002103004A1 (en) * 2001-06-15 2002-12-27 The Children's Hospital Of Philadelphia Surface modification for improving biocompatibility
AU2002324193A1 (en) * 2001-09-13 2003-03-24 Scientific Generics Limited Therapeutic insert and therapeutic method
WO2003037302A1 (en) * 2001-10-30 2003-05-08 Windsor J Brian Method and system for the co-isolation of cognate dna, rna and protein sequences and method for screening co-isolates for defined activities
AU2003278987A1 (en) * 2002-09-26 2004-04-19 The Children's Hospital Of Philadelphia Method of determining surface binding capacity
EP1687069A1 (de) * 2003-10-29 2006-08-09 Firmenich Sa Parfüm-abgabesysteme auf basis von anorganischen nanoteilchen
US20060263898A1 (en) * 2003-10-29 2006-11-23 Walter Paget Perfume delivery systems based on inorganic nano particles
US7449196B2 (en) * 2004-07-09 2008-11-11 Robert Sabin Anti tumor compositions and methods of use

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4323056A (en) * 1980-05-19 1982-04-06 Corning Glass Works Radio frequency induced hyperthermia for tumor therapy
DE3019764A1 (de) * 1980-05-23 1981-12-03 Basf Ag, 6700 Ludwigshafen Verfahren zur herstellung von synthetischem lepidokrokit
US4452773A (en) * 1982-04-05 1984-06-05 Canadian Patents And Development Limited Magnetic iron-dextran microspheres
US4826823A (en) 1985-02-05 1989-05-02 Warner-Lambert Company Methods of using 2-chloro-2'-deoxyadenosine-5'-phosphate and its salts
US4925678A (en) * 1987-04-01 1990-05-15 Ranney David F Endothelial envelopment drug carriers
SE8704157L (sv) * 1987-10-26 1989-04-27 Carbomatrix Ab C O Ulf Schroed Superparamagnetiska partiklar och foerfarande foer framstaellning daerav samt anvaendning
GB2221466A (en) * 1988-03-09 1990-02-07 Aluminum Co Of America Biologically reactive particles with biological, therapeutic and chromatographic applications
IE913240A1 (en) * 1990-09-14 1992-02-25 Syngenix Ltd Particulate agents
US5948384A (en) * 1990-09-14 1999-09-07 Syngenix Limited Particulate agents
AU8628291A (en) * 1990-09-25 1992-04-15 University Of Connecticut, The Prolonging expression of polynucleotides introduced into a cell
JP3357362B2 (ja) * 1990-12-19 2002-12-16 アドバンスド・マグネティクス・インク 多糖類を用いる治療薬のターゲティング
EP0566590B1 (de) * 1991-01-07 1997-03-19 Syngenix Limited Für endocytose geeignete teilchen
GB9119762D0 (en) * 1991-09-16 1991-10-30 Filler Aaron G Particulate agents for nmt

Also Published As

Publication number Publication date
JP3560969B2 (ja) 2004-09-02
EP0640350A2 (de) 1995-03-01
DK0640350T3 (da) 2002-08-05
US6153598A (en) 2000-11-28
DE69232547D1 (de) 2002-05-16
AU669128B2 (en) 1996-05-30
EP0640350A3 (de) 1995-12-13
US20020123478A1 (en) 2002-09-05
ES2176216T3 (es) 2002-12-01
CA2119145C (en) 2003-11-25
EP0610232A1 (de) 1994-08-17
JPH07501793A (ja) 1995-02-23
AU2567992A (en) 1993-04-27
US6809082B2 (en) 2004-10-26
EP0640350B1 (de) 2002-04-10
GB9119762D0 (en) 1991-10-30
WO1993005815A1 (en) 1993-04-01
CA2119145A1 (en) 1993-04-01

Similar Documents

Publication Publication Date Title
DE69609742D1 (de) Verbundene keramische Bauteile und Verfahren zur Herstellung davon
DE69617957D1 (de) Feine teilchen aus blütenförmigem porösem hydroxyapatit und verfahren zur herstellung
DE69232547T2 (de) Keramische Partikel und Verfahren zur ihren Herstellung
DE69201589D1 (de) Wachsumhüllte Partikel und Verfahren zur Herstellung derselben.
DE3855544T2 (de) Keramische Verbundwerkstoff und Verfahren zur Herstellung desselben
DE69528625D1 (de) Mehrschichtige Formteile und Verfahren zur Herstellung derselben
DE69116638D1 (de) Sintermetallteile und Verfahren zur ihrer Herstellung
DE69529966D1 (de) Tintenzusammensetzung und Verfahren zur Herstellung derselben
DE69638288D1 (de) Zusammensetzung und verfahren zur herstellung von keramischen materialien
DE69129746D1 (de) Modifiziertes Polysilazan und Verfahren zu seiner Herstellung
DE69212534D1 (de) Silicongummi-Partikel und Verfahren zur Herstellung
DE69226452T2 (de) Wärmebeständige schokolade und verfahren zur deren herstellung
DE69514413T2 (de) Keramische Beschichtigung und Verfahren zur Herstellung
DE69306663D1 (de) Nichtgebrannte Buntstift-Minen und Verfahren zur Herstellung derselben
DE69212550D1 (de) Verfahren und Gerät zur Herstellung von feinen Teilchen
DE69026735D1 (de) Harzzusammensetzung und Verfahren zur Herstellung davon
DE69211293T2 (de) Reibwerkstoff und Verfahren zur desen Herstellung
DE69119413D1 (de) Resistmaterial und verfahren zur herstellung
DE69328047T2 (de) Prothese und Verfahren zur deren Herstellung
DE69515584D1 (de) Keramische Schicht und Verfahren zur Herstellung derselben
DE3855587T2 (de) Keramische fasern und verfahren zur herstellung
DE69120556D1 (de) Polyäthylen und Verfahren zur Herstellung
DE69117137T2 (de) 2-Chlorpropionaldehyd-Trimer und Verfahren zur Herstellung davon
DE69322028T2 (de) Schmiedestück und Verfahren zur seiner Herstellung
DE69211959T2 (de) Plattenstruktur und Verfahren zur dessen Herstellung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee